New guidelines, growth opportunities, and investment in new technologies

Our Press & Policy

Stay up to date with the latest IVD sector news and developments in health policy.

May 21, 2024
BIVDA's Head of Regulatory Strategy, Professor Mike Messenger said "We welcome this new initiative from MHRA to adopt a 'smart' framework for reliance and recognition. This is in line with international best practice principles to increase regulatory efficiency and to ensure continued patient access to safe and effective IVDs."
Read More
Apr 09, 2024
The strategy will cover the period 2024-27 and includes a greater focus on antimicrobial resistance, and infectious disease, near-patient testing and pathway innovation, and genomics in cancer, infection, and both rare and common diseases. Members can still expect the maintenance of our current high levels of service and support in all areas.
Read More
Mar 25, 2024
The British In Vitro Diagnostic Association (BIVDA) is delighted to confirm the appointment of Helen Dent as Chief Executive, following a successful period as Interim Chief Executive. Helen will lead BIVDA in championing the medical diagnostics industry to politicians, policymakers, media and relevant stakeholders and in supporting members to improve patient outcomes.
Read More
Mar 07, 2024
Digital clinical diagnostics and diabetes home testing provider Digostics revealed today the results from its ground-breaking gestational diabetes mellitus (GDM) remote screening collaboration with University Hospital Southampton NHS Foundation Trust (UHS), a partnership that saw expectant mothers in Hampshire become the first globally to access the gold standard oral glucose tolerance test (OGTT) without needing to attend clinic.
Read More
Feb 26, 2024
A new coalition of industry and health charities, led by former Health Minister, raise the alarm over missed opportunities to tackle Antimicrobial Resistance in the UK. Action urgently needed to adopt point of care diagnostics and end years of delay in implementing key recommendations for antimicrobial stewardship.
Read More
Feb 07, 2024
OGT announces the opening of state-of-the-art facilities within the Oxford Technology Park. The move represents a multi-million-pound investment, fuelled by consistent company growth and growing customer demand. Equipped with cutting-edge technology, the facilities will drive development of OGT’s trusted SureSeq™ next generation sequencing (NGS) product portfolio, as well as deliver expert-led training and enhanced opportunities for collaboration.
Read More
Feb 05, 2024
BIVDA is pleased to announce the appointment of Professor Mike Messenger as our Head of Regulatory Strategy from 1st March 2024. Professor Mike Messenger is one of the UK’s most respected figures in the regulation of medical and in vitro diagnostics. He is a visiting Professor at the University of Leeds and was formerly Head of Diagnostics at the Medicines and Healthcare products Regulatory Agency (MHRA). During the COVID-19 pandemic, he led development of Target Product Profiles, supported gov...
Read More
Jan 30, 2024
Paul Fisher, Head of Policy, Programmes and Compliance said: “BIVDA are delighted to see the clear recognition that regulating of products places on manufacturers, and the focus on cross government solutions.  Linking health to innovation and science under one owner is something we have advocated for some time, but we would be keen to see the Department for Business and Trade involved.  Investment and export sales are key to the sector, and the UK’s economic economy.
Read More
Nov 15, 2023
In an NHS career spanning over 42 years, Angela was most recently the Deputy Chief Scientific Officer for NHS England until retiring from the role in October 2023. Angela brings a unique perspective to the Association, with her experience including; providing scientific oversight to the AMR diagnostics team in the Office of the Chief Scientific Officer, and working alongside NHS Test and Trace in COVID-19 laboratory development, product assay development, technical validation and providing scien...
Read More
Nov 13, 2023
BIVDA has noted the latest changes in the Prime Minister’s Cabinet and ministerial team. We would like to welcome the new Secretary of State for Health and Social Care, Victoria Atkins.
Read More
Page 1 of 34 FirstPrevious [1]

Interested in becoming a member? Join us!

Copyright 2024 BIVDA Ltd is registered in England
Company Number 2687137
Registered Office is 299 Oxford Street (5th floor),
London, W1C 2DZ. VAT Number 563105858